Victoria Socha

DocwireNews

Obesity is associated with risk for complications related to kidney biopsy. Long Qian, MD, and colleagues conducted an analysis to compare the safety and adequacy of kidney-biopsy procedures between obese and nonobese patients.Results were reported during a poster session at the American Society of Nephrology Kidney Week 2022. The poster was titled Safety and Adequacy of Kidney Biopsy Procedure in Patients With Obesity.The analysis included data from patients in the Yale University kidney biopsy cohort enrolled between 2015 and 2017. Following adjustment for prebiopsy risk factors and needle gauge, linear regression analysis was used to examine the association between class 2 obesity (defined as body mass index &ge;35 kg/m2) with postbiopsy drop in hematocrit and with the number of glomeruli sampled. A supplementary analysis using data from Johns Hopkins University was also performed.The Yale cohort included 337 patients, and of those, 23% (n=76) had obesity. Patients with obesity were more likely to undergo biopsy using an 18-gauge needle (vs 16-gauge needle) compared with nonobese patients (66% [n=48] vs 45% [n=113]; P=.002). In univariable analysis, patients with obesity had a lesser drop in hematocrit from pre- to postbiopsy (2.1% vs 3.0%; unadjusted difference, &ndash;0.95%; 95% CI, &ndash;0.14% to &ndash;1.75%). Following adjustment for prebiopsy factors, the difference was &ndash;0.92% (95% CI, &ndash;1.73% to &ndash;0.11%). There was no association between obesity and drop in hematocrit following further adjustment for needle gauge. Fewer glomeruli were sampled from patients with obesity.The Johns Hopkins cohort included 78 patients, and of those, 12 were obese. All biopsies at Johns Hopkins were performed using an 18-gauge needle. There was no association between obesity and drop in hematocrit. Results of meta-analyses of the two cohorts found no association between obesity and drop in hematocrit.In conclusion, the researchers said, &ldquo;Obese patients did not have a greater risk of postbiopsy hematocrit drop than those without obesity but tended to have fewer glomeruli available for diagnosis. Future studies could examine techniques to improve diagnostic yield of kidney biopsy for obese patients.&rdquo;Source: Qian L, Weinstein JN, Melchinger HC, et al. Safety and adequacy of kidney biopsy procedure in patients with obesity. TH-PO564. Abstract of a poster presented at the American Society of Nephrology Kidney Week 2022; November 3, 2022; Orlando, Florida.

Bradley Marder, MD

Joel M. Topf, MD, FACP

Gout Studies: Transplant Waitlisting and Bone Erosion

NKF Spring Clinical Meetings 2025

Jayme Locke, MD, MPH

The Promise of Xenotransplantation

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Latest News

Kidney Biopsy Safety and Adequacy in Patients with Obesity

ASN Kidney Week 2022

Obesity is associated with risk for complications related to kidney biopsy. Long Qian, MD, and colleagues conducted an analysis to compare the safety and adequacy of ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe